Although some of these studies did not reach statistical significance for OS, improvements in PFS and objective tumor responses suggest meaningful clinical benefit.
← all excerpts
Immunotherapy in hepatocellular carcinoma: translating mechanistic insights into clinical advances.
2
—
—
The sentences
Yet, the larger phase III KEYNOTE-240 trial narrowly missed statistical significance for overall and progression-free survival, even though numerical improvements were observed [ 84 ].